Integrum AB (publ) (FRA:6Y1)

Market Cap	20.74M +26.9%
Revenue (ttm)	8.92M +1.5%
Net Income	-3.24M
EPS	-0.13
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60
Open	0.7140
Previous Close	0.7240
Day's Range	0.7140 - 0.7140
52-Week Range	0.5880 - 1.0320
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 3, 2026

About Integrum AB

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. It also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputa...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1990
• Employees: 33
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6Y1

Financial Performance

In fiscal year 2026, Integrum AB's revenue was 91.43 million, an increase of 0.36% compared to the previous year's 91.10 million. Losses were -46.34 million, 50.4% more than in 2025.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error